NIDAN Stock Overview
Provides healthcare and diagnostic services in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Nidan Laboratories and Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹29.10 |
| 52 Week High | ₹41.15 |
| 52 Week Low | ₹27.00 |
| Beta | -0.28 |
| 11 Month Change | -1.19% |
| 3 Month Change | -13.26% |
| 1 Year Change | -15.90% |
| 33 Year Change | -60.86% |
| 5 Year Change | n/a |
| Change since IPO | -75.29% |
Recent News & Updates
Shareholder Returns
| NIDAN | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -2.5% | 1.9% | 0.5% |
| 1Y | -15.9% | 40.3% | 27.5% |
Return vs Industry: NIDAN underperformed the Indian Healthcare industry which returned 37.9% over the past year.
Return vs Market: NIDAN underperformed the Indian Market which returned 25.5% over the past year.
Price Volatility
| NIDAN volatility | |
|---|---|
| NIDAN Average Weekly Movement | 4.7% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: NIDAN has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: NIDAN's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 194 | Nitin Thorve | www.nidanhealthcare.co.in |
Nidan Laboratories and Healthcare Limited provides healthcare and diagnostic services in India. It offers diagnostic services, including pathology, radiology, cardiology, and neurology services. The company was founded in 1994 and is headquartered in Palghar, India.
Nidan Laboratories and Healthcare Limited Fundamentals Summary
| NIDAN fundamental statistics | |
|---|---|
| Market cap | ₹404.49m |
| Earnings (TTM) | -₹40.53m |
| Revenue (TTM) | ₹228.86m |
1.8x
P/S Ratio-10.0x
P/E RatioIs NIDAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NIDAN income statement (TTM) | |
|---|---|
| Revenue | ₹228.86m |
| Cost of Revenue | ₹20.30m |
| Gross Profit | ₹208.56m |
| Other Expenses | ₹249.10m |
| Earnings | -₹40.53m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.92 |
| Gross Margin | 91.13% |
| Net Profit Margin | -17.71% |
| Debt/Equity Ratio | 17.5% |
How did NIDAN perform over the long term?
See historical performance and comparison